Grand Rounds

Enhancing T Cell Cytotoxicity with Dual Checkpoint Blockade in Patients with AML and The Anti-Xa Heparin Assay for Monitoring Patients Receiving Unfractionated Heparin Continuous Infusion & VTE Prophylaxis in Total Hip and Knee Arthroplasty Patients



Date
May 25, 2016
Time
8:00 AM - 9:00 AM
Speaker(s)
Kirsten Boughan, DO and Emily Whitman Purves, MD
Fellow, Division of Hematology/Oncology
Location
UPMC Cancer Pavilion, 2nd floor, Herberman Auditorium
Contact
Carolyn Miller
Conference Coordinator


412-692-2751
millerc5@upmc.edu
Description